143 related articles for article (PubMed ID: 2433279)
1. Determination of the bifunctional properties of high molecular weight kininogen by studies with monoclonal antibodies directed to each of its chains.
Schmaier AH; Schutsky D; Farber A; Silver LD; Bradford HN; Colman RW
J Biol Chem; 1987 Jan; 262(3):1405-11. PubMed ID: 2433279
[TBL] [Abstract][Full Text] [Related]
2. High molecular weight kininogen is an inhibitor of platelet calpain.
Schmaier AH; Bradford H; Silver LD; Farber A; Scott CF; Schutsky D; Colman RW
J Clin Invest; 1986 May; 77(5):1565-73. PubMed ID: 2422211
[TBL] [Abstract][Full Text] [Related]
3. Radioimmunoassays of human high and low molecular weight kininogens in plasmas and platelets.
Kerbiriou-Nabias DM; Garcia FO; Larrieu MJ
Br J Haematol; 1984 Feb; 56(2):273-86. PubMed ID: 6691922
[TBL] [Abstract][Full Text] [Related]
4. High molecular weight kininogen: localization in the unstimulated and activated platelet and activation by a platelet calpain(s).
Schmaier AH; Smith PM; Purdon AD; White JG; Colman RW
Blood; 1986 Jan; 67(1):119-30. PubMed ID: 3000474
[TBL] [Abstract][Full Text] [Related]
5. Detection of in vitro and in vivo cleavage of high molecular weight kininogen in human plasma by immunoblotting with monoclonal antibodies.
Berrettini M; Lämmle B; White T; Heeb MJ; Schwarz HP; Zuraw B; Curd J; Griffin JH
Blood; 1986 Aug; 68(2):455-62. PubMed ID: 3730610
[TBL] [Abstract][Full Text] [Related]
6. Cleavage of human high-molecular weight kininogen by purified kallikreins and upon contact activation of plasma.
Reddigari S; Kaplan AP
Blood; 1988 May; 71(5):1334-40. PubMed ID: 2451949
[TBL] [Abstract][Full Text] [Related]
7. Quantification of human high molecular weight kininogen by immunoblotting with a monoclonal anti-light chain antibody.
Reddigari S; Kaplan AP
J Immunol Methods; 1989 Apr; 119(1):19-25. PubMed ID: 2651524
[TBL] [Abstract][Full Text] [Related]
8. Monoclonal antibody to human high-molecular-weight kininogen recognizes its prekallikrein binding site and inhibits its coagulant activity.
Reddigari SR; Kaplan AP
Blood; 1989 Aug; 74(2):695-702. PubMed ID: 2752143
[TBL] [Abstract][Full Text] [Related]
9. Autoantibodies to phosphatidylethanolamine (PE) recognize a kininogen-PE complex.
Sugi T; McIntyre JA
Blood; 1995 Oct; 86(8):3083-9. PubMed ID: 7579402
[TBL] [Abstract][Full Text] [Related]
10. Production and characterization of monoclonal antibodies directed against high and low molecular weight kininogens.
Hentges F; Kohnen M; Grigioni F; Reichert P; Humbel R; Schneider F
Bull Soc Sci Med Grand Duche Luxemb; 1994; 131(2):9-17. PubMed ID: 7820912
[TBL] [Abstract][Full Text] [Related]
11. High molecular weight kininogen binds to Mac-1 on neutrophils by its heavy chain (domain 3) and its light chain (domain 5).
Wachtfogel YT; DeLa Cadena RA; Kunapuli SP; Rick L; Miller M; Schultze RL; Altieri DC; Edgington TS; Colman RW
J Biol Chem; 1994 Jul; 269(30):19307-12. PubMed ID: 8034694
[TBL] [Abstract][Full Text] [Related]
12. Insights on monoclonal antibodies to kininogens' heavy chain which influence kininogens' binding to platelets.
Jiang Y; Nawarawong W; Meloni FJ; Schmaier AH
Thromb Haemost; 1992 Aug; 68(2):143-8. PubMed ID: 1412158
[TBL] [Abstract][Full Text] [Related]
13. Comparison of properties of monoclonal and polyclonal antibodies against the light chain of human high molecular weight kininogen.
Kleniewski J; Dingle S; Donaldson VH
J Lab Clin Med; 1988 Jan; 111(1):93-103. PubMed ID: 2447215
[TBL] [Abstract][Full Text] [Related]
14. Mapping of functional domains of human high molecular weight and low molecular weight kininogens using murine monoclonal antibodies.
Ishiguro H; Higashiyama S; Ohkubo I; Sasaki M
Biochemistry; 1987 Nov; 26(22):7021-9. PubMed ID: 2447941
[TBL] [Abstract][Full Text] [Related]
15. Structural changes of plasma high molecular weight kininogen after in vitro activation and in sepsis.
Schmaier AH; Farber A; Schein R; Sprung C
J Lab Clin Med; 1988 Aug; 112(2):182-92. PubMed ID: 2456360
[TBL] [Abstract][Full Text] [Related]
16. Determination of human low molecular weight kininogen by immunoassay.
Jerabek I; Stetina Z; Furtner R; Binder BR; Maier M
Agents Actions Suppl; 1992; 38 ( Pt 1)():257-66. PubMed ID: 1281608
[TBL] [Abstract][Full Text] [Related]
17. Relation between structure and correcting activity of bovine high molecular weight kininogen upon the clotting time of Fitzgerald-trait plasma.
Scicli AG; Waldmann R; Guimaraes JA; Scicli G; Carretero OA; Kato H; Han YN; Iwanaga S
J Exp Med; 1979 Apr; 149(4):847-55. PubMed ID: 429963
[TBL] [Abstract][Full Text] [Related]
18. High molecular weight kininogen-binding site of prekallikrein probed by monoclonal antibodies.
Hock J; Vogel R; Linke RP; Müller-Esterl W
J Biol Chem; 1990 Jul; 265(20):12005-11. PubMed ID: 1694851
[TBL] [Abstract][Full Text] [Related]
19. Immunological characterization of rat kininogens with monoclonal antibodies to T-kininogen. Distinction between the different domains of T-kininogen and the multiple rat kininogens.
Lesage S; Bouhnik J; Richoux JP; Baussant T; Gauthier F; Eager K; Corvol P; Alhenc-Gelas F
Eur J Biochem; 1992 Mar; 204(2):501-8. PubMed ID: 1541265
[TBL] [Abstract][Full Text] [Related]
20. Further characterization of monoclonal antibodies against rat plasma kallikrein, rat low molecular weight kininogen and synthetic bradykinin.
Bedi GS; Back N
Adv Exp Med Biol; 1989; 247B():223-30. PubMed ID: 2610064
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
